ArticleFrontiers in pharmacology2021

Gamabufotalin Inhibits Osteoclastgenesis and Counteracts Estrogen-Deficient Bone Loss in Mice by Suppressing RANKL-Induced NF-κB and ERK/MAPK Pathways.

Kaiqiang Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.